Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective cohort study by InspECT on safety and efficacy of electrochemotherapy for cutaneous tumors and metastases depending on ulceration.
Claussen CS, Moir G, Bechara FG, Orlando A, Matteucci P, Mowatt D, Clover AJP, Mascherini M, Gehl J, Muir T, Sersa G, Groselj A, Odili J, Giorgione R, Campana LG, Bertino G, Curatolo P, Banerjee S, Kis E, Quaglino P, Pritchard-Jones R, De Terlizzi F, Grischke EM, Kunte C. Claussen CS, et al. Among authors: grischke em. J Dtsch Dermatol Ges. 2022 Apr;20(4):470-481. doi: 10.1111/ddg.14699. Epub 2022 Apr 5. J Dtsch Dermatol Ges. 2022. PMID: 35384261
Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019).
Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, Kunte C, Muir T, Brizio M, Sersa G, Pritchard Jones R, Moir G, Orlando A, Banerjee SM, Kis E, McCaul JA, Grischke EM, Matteucci P, Mowatt D, Bechara FG, Mascherini M, Lico V, Giorgione R, Seccia V, Schepler H, Pecorari G, MacKenzie Ross AD, Bisase B, Gehl J. Clover AJP, et al. Among authors: grischke em. Eur J Cancer. 2020 Oct;138:30-40. doi: 10.1016/j.ejca.2020.06.020. Epub 2020 Aug 21. Eur J Cancer. 2020. PMID: 32836172
Electrochemotherapy for Breast Cancer-Results From the INSPECT Database.
Matthiessen LW, Keshtgar M, Curatolo P, Kunte C, Grischke EM, Odili J, Muir T, Mowatt D, Clover JP, Liew SH, Dahlstroem K, Newby J, Letulé V, Stauss E, Humphreys A, Banerjee S, Klein A, Rotunno R, de Terlizzi F, Gehl J. Matthiessen LW, et al. Among authors: grischke em. Clin Breast Cancer. 2018 Oct;18(5):e909-e917. doi: 10.1016/j.clbc.2018.03.007. Epub 2018 Mar 14. Clin Breast Cancer. 2018. PMID: 29673795
Prospektive Kohortenstudie von InspECT zur Sicherheit und Wirksamkeit der Elektrochemotherapie bei Hauttumoren und Metastasen in Abhängigkeit von Ulzeration.
Claussen CS, Moir G, Bechara FG, Orlando A, Matteucci P, Mowatt D, Clover AJP, Mascherini M, Gehl J, Muir T, Sersa G, Groselj A, Odili J, Giorgione R, Campana LG, Bertino G, Curatolo P, Banerjee S, Kis E, Quaglino P, Pritchard-Jones R, De Terlizzi F, Grischke EM, Kunte C. Claussen CS, et al. Among authors: grischke em. J Dtsch Dermatol Ges. 2022 Apr;20(4):470-482. doi: 10.1111/ddg.14699_g. J Dtsch Dermatol Ges. 2022. PMID: 35446500
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators. Tutt ANJ, et al. N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3. N Engl J Med. 2021. PMID: 34081848 Free PMC article. Clinical Trial.
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials.
Goetz MP, Okera M, Wildiers H, Campone M, Grischke EM, Manso L, André VAM, Chouaki N, San Antonio B, Toi M, Sledge GW Jr. Goetz MP, et al. Among authors: grischke em. Breast Cancer Res Treat. 2021 Apr;186(2):417-428. doi: 10.1007/s10549-020-06029-y. Epub 2021 Jan 3. Breast Cancer Res Treat. 2021. PMID: 33392835 Free PMC article. Clinical Trial.
178 results